IART Stock Recent News
IART LATEST HEADLINES
PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 42nd Annual J.P. Morgan Healthcare conference on January 10, 2024 at 1:30pm ET.
Integra (IART) will be among the top suppliers of ENT products and technologies following the Acclarent acquisition.
Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q3 2023 Earnings Call October 25, 2023 8:30 AM ET Company Participants Chris Ward - Senior Director of Investor Relations Jan De Witte - President and Chief Executive Officer Lea Daniels Knight - Chief Financial Officer Conference Call Participants Young Li - Jefferies Vik Chopra - Wells Fargo Robbie Marcus - J.P. Morgan Ryan Zimmerman - BTIG Craig Bijou - Bank of America Securities Richard Newitter - Truist Securities Steven Lichtman - Oppenheimer and Company Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James David Turkaly - JMP Securities Operator Good day, and thank you for standing by.
Integra LifeSciences (IART) came out with quarterly earnings of $0.76 per share, missing the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.86 per share a year ago.
Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and Idexx Laboratories (IDXX). But which of these two stocks offers value investors a better bang for their buck right now?
International expansion and the strong prospects of the CSS segment bode well for Integra (IART).
PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2023 financial results on Wednesday, October 25, 2023, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET.
PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2023 Wells Fargo Healthcare Conference on September 6, 2023 at 1:30 p.m. EST.
Investors continue to be optimistic about Integra (IART) based on the prospects of its CSS segment and a stable liquidity position.
Integra (IART) reported earnings 30 days ago. What's next for the stock?